Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Pharmacology

• Publication date

  2005-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0706372PMID 16113689PMCID PMC1751204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine

  2008cited by this paper
• Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs.

  2005cited by this paper
• Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats.

  2005cited by this paper
• Pharmacology of drugs used to treat osteoarthritis in veterinary practice

  2004cited by this paper
• The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans

  2004cited by this paper
• Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice.

  2003cited by this paper
• Effect of rofecoxib on nociception and the serotonin system in the rat brain

  2002cited by this paper
• Selective inhibitors of cyclo‐oxygenase‐2 (COX‐2) induce hypoalgesia in a rat paw model of inflammation

  2002cited by this paper
• Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat.

  2001cited by this paper
• Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

  2001cited by this paper
• A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.

  2001cited by this paper
• Evaluation of the clinical efficacy of meloxicam in cats with painful locomotor disorders.

  2001cited by this paper
• Postoperative analgesia in the cat after ovariohysterectomy by use of carprofen, ketoprofen, meloxicam or tolfenamic acid.

  2000cited by this paper
• Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats.

  1998cited by this paper
• Integrated Pharmacokinetic–Pharmacodynamic Model for Acetaminophen, Ibuprofen, and Placebo Antipyresis in Children

  1998cited by this paper
• Pharmacokinetics of meloxicam in animals and the relevance to humans.

  1998cited by this paper
• Predicting Effective Drug Concentrations for Individual Patients

  1998cited by this paper
• Pharmacokinetic–Pharmacodynamic Modeling of Tolmetin Antinociceptive Effect in the Rat Using an Indirect Response Model: A Population Approach

  1998cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat.

  1997cited by this paper
• Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

  1997cited by this paper
• A review of the clinical pharmacokinetics of meloxicam.

  1996influential reference
• Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.

  1996cited by this paper
• Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

  1995cited by this paper
• Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.

  1995cited by this paper
• Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat.

  1995cited by this paper
• Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling.

  1995cited by this paper
• Quantitative evaluation of an experimental inflammation induced with Freund's complete adjuvant in dogs.

  1994cited by this paper
• Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.

  1994cited by this paper
• Comparison of four basic models of indirect pharmacodynamic responses

  1993cited by this paper
• The Case for Preclinical Pharmacodynamics

  1993influential reference
• Negative power functions of time in pharmacokinetics and their implications

  1985cited by this paper
• Determination of inflamed paw surface temperature in rats.

  1984cited by this paper
• Therapeutic reduction of ongoing carrageenin-induced inflammation by lipoxygenase, but not cyclooxygenase inhibitors

  1984cited by this paper
• [Thermometry in experimental inflammation. I. Studies on the circadian rhythm of the paw temperature in healthy rats and temperature behavior in acute inflammation after injection of kaolin, carrageenin and dextran].

  1983cited by this paper
• Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations

  1978cited by this paper

• Evaluating Orally Administered Meloxicam-Loaded Polymeric Nanocapsules in Female Dogs: A Population Pharmacokinetic Modeling Study

  2026cites this paper
• Pharmacokinetic profile of a single intramuscular or oral dose of meloxicam in red kangaroos (Osphranter rufus).

  2025cites this paper
• Suitability of prolonged meloxicam treatment in mice seems limited due to unfavorable pharmacokinetics, side effects, and impact on home-cage behaviors

  2025cites this paper
• Antinociceptive and Cardiorespiratory Effects of a Single Dose of Dexmedetomidine in Laboratory Mice Subjected to Craniotomy under General Anaesthesia with Isoflurane and Carprofen or Meloxicam

  2024cites this paper
• Effect of poly(ε-caprolactone) microspheres on population pharmacokinetic/pharmacodynamic model of a simple coumarin

  2024cites this paper
• Pharmacokinetics of Meloxicam in Different Animal Species: A Comprehensive Review.

  2024cites this paper
• Pharmacokinetics of Injectable Meloxicam and Buprenorphine in the Naked Mole-Rat (Heterocephalus glaber).

  2024influential citation
• Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii).

  2024cites this paper
• Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner-based assessment of pain.

  2023cites this paper
• Pharmacokinetics of the analgesic and anti-inflammatory drug meloxicam after administration of multiple doses to nursehound sharks (Scyliorhinus stellaris).

  2023cites this paper
• Disposition kinetics of meloxicam in green sea turtles (Chelonia mydas) after intravenous and intramuscular administrations.

  2023cites this paper
• Optimising postoperative pain management in cats undergoing ovariohysterectomy.

  2023cites this paper
• A Review of Long-acting Parenteral Analgesics for Mice and Rats.

  2022cites this paper
• Pharmacokinetic/pharmacodynamic modeling of ketoprofen and flunixin at piglet castration and tail‐docking

  2022cites this paper
• PHARMACOKINETICS OF A SINGLE DOSE OF INTRAMUSCULAR AND ORAL MELOXICAM IN YELLOW STINGRAYS (UROBATIS JAMAICENSIS)

  2022cites this paper
• Analgesia for Sheep in Commercial Production: Where to Next?

  2021cites this paper
• Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus (Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling.

  2020influential citation
• Comparison of perioperative analgesia using the infiltration of the surgical site with ropivacaine alone and in combination with meloxicam in cats undergoing ovariohysterectomy

  2020cites this paper
• Efficacy of meloxicam in a pain model in sheep

  2019cites this paper
• Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders.

  2019cites this paper
• Pharmacokinetics and absolute oral bioavailability of meloxicam in guinea pigs (Cavia porcellus).

  2019cites this paper
• Clinical Management of Pain in Rodents.

  2019cites this paper
• Pharmacokinetics of the novel COX‐2 selective inhibitor vitacoxib in cats: The effects of feeding and dose

  2019cites this paper
• Pharmacokinetic/pharmacodynamic relationship of pulmonary administration methods for milrinone : a translational approach

  2018cites this paper
• Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection

  2018cites this paper
• PHARMACOKINETICS OF MELOXICAM FOLLOWING A SINGLE ORAL DOSE IN MALAYAN FLYING FOXES (PTEROPUS VAMPYRUS)

  2018cites this paper
• Pharmacokinetics and Pharmacodynamics of Nebulized and Intratracheal Milrinone in a Swine Model of Hypercapnia Pulmonary Hypertension.

  2018cites this paper
• Pharmacokinetic Profiles of Meloxicam and Sustained-release Buprenorphine in Prairie Dogs (Cynomys ludovicianus).

  2017cites this paper
• Pharmacokinetic Profiles of Meloxicam and Sustained-release Buprenorphine in Prairie Dogs (Cynomys ludovicianus).

  2017cites this paper
• Pharmacokinetics of Single-dose Subcutaneous Meloxicam Injections in Black-tailed Prairie Dogs (Cynomys ludovicianus).

  2017cites this paper
• Plasma Concentration of Meloxicam in Pediatric Rats.

  2017cites this paper
• General Pharmacology of Anesthetic and Analgesic Drugs

  2017cites this paper
• Systematic review of the behavioural assessment of pain in cats

  2016cites this paper
• Biochemical and epidemiological investigations of non-steroidal anti-inflammatory drug usage and related side effects in equids

  2016cites this paper
• Research Article CODEN: IJPRNK ISSN: 2277-8713 HM Elsabbagh, IJPRBS, 2016; Volume 5(1): 136-151 IJPRBS

  2016cites this paper
• PHARMACOKINETIC EVALUATION OF MELOXICAM AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION IN NILE TILAPIA (OREOCHROMIS NILOTICUS)

  2016cites this paper
• Pharmacokinetics of meloxicam in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections.

  2016cites this paper
• Coptisine from Coptis chinensis inhibits production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells.

  2016influential citation
• In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats

  2016cites this paper
• Development of hysteresis analysis as a model-independent approach to assess temporal dissociation in pharmacokinetics and pharmacodynamics

  2016cites this paper
• Comparison of oral non-steroidal anti-inflammatory drugs in cautery dehorned calves

  2015cites this paper
• Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

  2015cites this paper
• Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review.

  2015cites this paper
• Pharmacokinetic aspects of meloxicam in koalas: including its hepatic microsomal metabolism compared with other selected species

  2015cites this paper
• Application of fast-track surgery principles to evaluate effects of atipamezole on recovery and analgesia following ovariohysterectomy in cats anesthetized with dexmedetomidine-ketamine-hydromorphone.

  2015cites this paper
• Pharmacokinetics of sustained-release analgesics in mice.

  2014cites this paper
• A SIMPLE NON-INVASIVE COMPARATIVE LOG LINEAR PK-PD MODEL OF DEXIBUPROFEN TABLETS IN INDIAN HEALTHY HUMAN MALE VOLUNTEERS

  2014cites this paper
• Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).

  2014cites this paper
• Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.

  2014influential citation
• Neuroprotective effect of resveratrol on arsenic trioxide–induced oxidative stress in feline brain

  2014cites this paper
• Resveratrol, a Natural Antioxidant, Has a Protective Effect on Liver Injury Induced by Inorganic Arsenic Exposure

  2014cites this paper
• Semi-mechanistic Modelling of the Analgesic Effect of Gabapentin in the Formalin-Induced Rat Model of Experimental Pain

  2014cites this paper
• Pharmacokinetics of meloxicam administered orally to rabbits (Oryctolagus cuniculus) for 29 days.

  2014cites this paper
• Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administration.

  2013cites this paper
• Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress

  2013cites this paper
• Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress

  2013cites this paper
• Resveratrol ameliorates the oxidative damage induced by arsenic trioxide in the feline lung.

  2013cites this paper
• Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses.

  2013cites this paper
• Pharmacokinetics of intravenously and orally administered meloxicam in sheep.

  2013cites this paper
• PHARMACOKINETIC / PHARMACODYNAMIC ( PK / PD ) MODELING OF ANTI-INFLAMMATORY EFFECT OF MELOXICAM , A PREFERENTIAL CYCLOOXYGENASE-2 INHIBITOR , IN RATS

  2013cites this paper
• Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog

  2013cites this paper
• Pharmacokinetic/Pharmacodynamic (PK/PD) modeling of antipyretic effect of meloxicam: A preferential cyclooxygenase inhibitor in rat

  2013cites this paper
• A fully caninised anti-NGF monoclonal antibody for pain relief in dogs

  2013cites this paper
• Meloxicam Usage in Cats, and its Potential Adverse Effects on the Renal Function

  2013cites this paper
• Semi-solid topical formulations containing nimesulide-loaded nanocapsules showed in-vivo anti-inflammatory activity in chronic arthritis and fibrovascular tissue models

  2012cites this paper
• The pharmacokinetics and metabolism of meloxicam in camels after intravenous administration.

  2012influential citation
• Pharmacokinetic/pharmacodynamic modeling in inflammation.

  2012cites this paper
• Semi-mechanistic Modeling of the Interaction Between the Central and Peripheral Effects in the Antinociceptive Response to Lumiracoxib in Rats

  2012cites this paper
• Pharmacokinetic-pharmacodynamic modeling of diclofenac in normal and Freund's complete adjuvant-induced arthritic rats

  2012cites this paper
• Comparison of injectable robenacoxib versus meloxicam for peri-operative use in cats: results of a randomised clinical trial.

  2012influential citation
• Development and validation of a tissue cage model of acute inflammation in the cat.

  2012cites this paper
• Pharmacokinetics and pharmacodynamic effects of meloxicam in piglets subjected to a kaolin inflammation model.

  2011cites this paper
• Pharmacokinetics of meloxicam in adult goats and its analgesic effect in disbudded kids.

  2011cites this paper
• Paw Inflammation Model in Dogs for Preclinical Pharmacokinetic/Pharmacodynamic Investigations of Nonsteroidal Anti-Inflammatory Drugs

  2011cites this paper
• Dose range finding study for the efficacy of meloxicam administered prior to sodium urate-induced synovitis in cats.

  2011cites this paper
• Simultaneous Pharmacokinetic–Pharmacodynamic Modeling

  2011cites this paper
• Population pharmacokinetic–pharmacodynamic–disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis

  2011cites this paper
• Ketoprofen in piglets: enantioselective pharmacokinetics, pharmacodynamics and PK/PD modelling.

  2011cites this paper
• Topical anti-inflammatory action of Caryocar villosum oil (Aubl) Pers.

  2011cites this paper
• Pharmacokinetic ⁄ pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation

  2011cites this paper
• Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.

  2010cites this paper
• What do we really know about the drugs we use to treat chronic pain?

  2010cites this paper
• Postoperative analgesic efficacy of meloxicam compared to tolfenamic acid in cats undergoing orthopaedic surgery.

  2010cites this paper
• Pharmacokinetic–pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase‐2, in rats

  2010influential citation
• Excretion mass balance evaluation, metabolite profile analysis and metabolite identification in plasma and excreta after oral administration of [14C]-meloxicam to the male cat: preliminary study.

  2010cites this paper
• Évaluation de protocoles analgésiques pour la prise en charge de la douleur périopératoire lors d'ovariectomie de chatte

  2010cites this paper
• Population pharmacokinetic modelling and simulation of single and multiple dose administration of meloxicam in cats.

  2009influential citation
• Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib.

  2009cites this paper
• A pilot study: sodium urate synovitis as an acute model of inflammatory response using objective and subjective criteria to evaluate arthritic pain in cats.

  2008cites this paper
• Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib

  2008cites this paper
• Pharmacokinetics and pharmacodynamics of ketoprofen plasters

  2008cites this paper
• An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals.

  2008cites this paper
• Efeitos analgésico, hemostático, renal e digestório na administração perioperatória de vedaprofeno, tramadol ou de sua associação em felinos submetidos à ovariosalpingohisterectomia

  2007cites this paper
• Carprofen and buprenorphine prevent hyperalgesia in a model of inflammatory pain in cats.

  2007cites this paper
• Evaluation of the use of thermal thresholds to investigate NSAID analgesia in a model of inflammatory pain in cats

  2007cites this paper
• RT06 Pharmacological and other sources of variability in response to drugs including lack of compliance to prescribed medication

  2006cites this paper